List of insiders holdings for CASI Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CELGENE CORP 10% Owner | 2006-03-10 20:19:48 | 24,614,864 0 | 24,614,864 | Form 13D |
| Wealth Strategy Holding Ltd 10% Owner | 2020-02-19 16:05:17 | 10,684,625 0 | 10,684,625 | Form 13G |
| Li Dapeng 10% Owner | 2019-02-06 16:06:47 | 9,364,130 0 | 9,364,130 | Form 13G |
| SPECTRUM PHARMACEUTICALS INC Spectrum Pharmaceuticals Cayman L.P. 10% Owner | 2021-04-30 16:11:30 | 6,886,956 0 | 6,886,956 | Form 13D |
| He Wei-Wu Chairman and CEO 10% Owner | 2022-06-21 16:26:09 | 2,761,349 0 | 2,761,349 | Form 13D |
| IDG-Accel China Growth Fund III L.P. IDG-Accel China III Investors L.P. IDG-Accel China Growth Fund III Associates L.P. IDG-Accel China Growth Fund GP III Associates Ltd. Ho Chi Sing Zhou Quan 10% Owner | 2023-02-21 07:33:47 | 1,053,638 0 | 1,053,638 | Form 13D |
| SPARKLE BYTE LTD SNOW MOON LTD TIANJIN JINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP) HE XIE AI QI INVESTMENT MANAGEMENT (BEIJING) CO. LTD. Li Jianguang Lin Dongliang Yang Fei Zhang Suyang Shong Hugo 10% Owner | 2024-02-20 11:40:06 | 1,019,852 0 | 1,019,852 | Form 13D |
| SPARKLE BYTE LTD SNOW MOON LTD TIANJIN JINGRAN MANAGEMENT CENTER (LIMITED PARTNERSHIP) HE XIE AI QI INVESTMENT MANAGEMENT (BEIJING) CO. LTD. Li Jianguang Lin Dongliang Yang Fei Shong Hugo 10% Owner | 2024-02-20 11:40:06 | 1,019,852 0 | 1,019,852 | Form 13D |
| Xu Weihao Chief Financial Officer | 2020-12-18 16:05:26 | 800,000 10,000 | 810,000 | Form 4 |
| Zhang Larry President | 2021-07-26 18:08:05 | 800,000 0 | 800,000 | Form 4 |
| Chi George Chief Financial Officer | 2018-10-02 19:20:33 | 400,000 0 | 400,000 | Form 4 |
| Wu Yue Alexander Director | 2022-05-26 16:13:08 | 388,387 0 | 388,387 | Form 4 |
| Salisbury Franklin Cary jr Director | 2022-05-26 16:12:18 | 388,387 0 | 388,387 | Form 4 |
| Zhou Quan Director | 2022-05-26 16:24:15 | 380,645 0 | 380,645 | Form 4 |
| Huang James Director | 2022-09-08 18:51:39 | 191 371,517 | 371,708 | Form 4 |
| SHROTRIYA RAJESH C MD Director | 2022-05-26 16:11:29 | 345,806 0 | 345,806 | Form 4 |
| Bliss Thomas H Jr SVP, Bus. & Corp. Development | 2008-06-19 12:03:56 | 300,000 0 | 300,000 | Form 4 |
| Burns James S President and CEO | 2008-09-17 10:20:14 | 185,300 0 | 185,300 | Form 4 |
| Wehmeir-Davis Kathy Principal Accounting Officer | 2009-01-29 14:39:06 | 140,000 0 | 140,000 | Form 4 |
| CAPE RONALD Director | 2007-06-18 15:12:04 | 95,533 0 | 95,533 | Form 4 |
| Hu Cynthia W. COO, Gen Counsel & Secretary | 2019-01-31 19:19:27 | 75,000 0 | 75,000 | Form 4 |
| KNIGHT PETER S Director | 2010-01-28 15:54:37 | 55,000 0 | 55,000 | Form 4 |
| Ren Ken Keyong Director | 2019-06-21 17:01:22 | 51,538 0 | 51,538 | Form 4 |
| RANDALL MARK C M Director | 2012-03-14 16:42:40 | 50,000 0 | 50,000 | Form 4 |
| TARNOW MICHAEL M Director | 2012-01-25 18:15:04 | 50,000 0 | 50,000 | Form 4 |
| Corrado Marc VP Corporate Development | 2006-12-20 12:47:24 | 50,000 0 | 50,000 | Form 4 |
| JOHNSON JAMES D Secretary of the Board | 2003-10-23 09:38:35 | 40,000 0 | 40,000 | Form 4 |
| BUSH DWIGHT L Director | 2013-05-31 18:47:00 | 37,500 0 | 37,500 | Form 4 |
| HUNTER CEVERA JENNIE Director | 2013-05-31 18:33:56 | 37,500 0 | 37,500 | Form 4 |
| Wu Alex Director | 2018-07-03 15:36:41 | 35,000 0 | 35,000 | Form 4 |
| Mak Tak W. Director | 2016-03-04 16:48:01 | 35,000 0 | 35,000 | Form 4 |
| Sidor Carolyn F V.P. and Chief Medical Officer | 2011-01-12 16:19:55 | 30,000 0 | 30,000 | Form 4 |
| CAMPBELL NEIL J President and COO | 2004-05-07 12:52:14 | 25,000 0 | 25,000 | Form 4 |
| BROOKS DONALD S Director | 2012-01-25 18:22:26 | 25,000 0 | 25,000 | Form 4 |
| Bair Kenneth Walter SVP, Research and Development | 2008-03-25 12:14:17 | 20,000 0 | 20,000 | Form 4 |
| Ren Ken CEO and Director | 2016-01-21 14:44:20 | 15,000 0 | 15,000 | Form 4 |
| Bray Mark R Vice President, Research | 2011-01-12 16:13:17 | 10,000 0 | 10,000 | Form 4 |
| SAGLIO DANE R Chief Financial Officer | 2008-03-24 07:24:31 | 7,300 0 | 7,300 | Form 4 |
| Zukiwski Alexander A EVP and Chief Medical Officer | 2022-09-09 16:01:37 | 3,000 0 | 3,000 | Form 4 |
| KLEIN UDO Senior Vice President of R&D | 2004-09-07 11:55:56 | 1,800 0 | 1,800 | Form 4 |
| CAPITELLI SARA B VP Fin & Principal Account Off | 2018-07-13 17:09:19 | 0 0 | 0 | Form 4 |